Israeli Scientists Prepare to Implant Lab-Grown Nerve Tissue in Paralyzed Patients

Researchers in Israel are preparing for a groundbreaking medical procedure that involves implanting a section of nerve tissue, grown from a patient's own cells, into individuals with paralysis. The technology was developed by Professor Tal Dvir's team at Tel Aviv University.

The process begins by reprogramming a patient's cells into stem cells, effectively reverting them to a state where they can differentiate into various bodily tissues. These stem cells are then cultivated into nerve cells and used to construct a personalized, three-dimensional implant, essentially a biological patch for damaged spinal cord tissue.

Matricelf, a company collaborating on the project, along with the Loewenstein Rehabilitation Center, is currently selecting potential patients and collecting blood samples to begin the implant manufacturing process. This production phase takes several months.

The first surgery is tentatively scheduled for the first half of 2027 at Sheba Medical Center. This advancement challenges the long-held belief that spinal cord injuries are largely irreparable, signaling a new era in regenerative medicine where organs could potentially be "grown" to replace damaged ones.